The research funded will help inform policy decisions during the novel coronavirus pandemic
The selective RET kinase inhibitor was cleared under the regulator’s accelerated approval process
The groups will explore novel methods to characterise pluripotent stem cells for the manufacture of regenerative medicine products
With its megamerger with Allergan finally in the books, AbbVie is officially a colossus with a bustling drug […]
Regeneron has been at the forefront of the COVID-19 fight for months with partnered med Kevzara in clinical trials […]
Sanofi is touting a clinical victory that puts recently approved Sarclisa—in a regimen that also contains Amgen’s Kyprolis—on […]
Indian drugmaker Dr. Reddy’s Laboratories has had its share of run-ins with the FDA over manufacturing problems at a […]
University of Utah engineer is developing a fast, reusable test for COVID-19 that works with cellphones.
With severe blood disorders, such as leukemia, doctors often rely on leukapheresis, a procedure in which large machines […]
It’s been driving policy decisions since covid-19 emerged in late 2019, but what is the R number, and […]